When first-line treatment isn’t enough, what next? Emma and Mark explore the role of additional anti-epileptic medications such as potassium bromide, levetiracetam and more. With an evidence-based view of expectations and side effects, they also dive into complementary approaches. From MCT diets and CBD oil to the emerging relevance of the gut-brain axis, this episode helps clinicians navigate a crowded therapeutic space with evidence, empathy and nuance.

Access Dômes Pharma Vet resources at domespharma.co.uk/the-vet-vault/